Geode Capital Management’s Keros Therapeutics KROS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.1M | Buy |
|
|||||
|
2025
Q1 | $8.22M | Buy |
|
|||||
|
2024
Q4 | $12.1M | Buy |
|
|||||
|
2024
Q3 | $42.1M | Buy |
|
|||||
|
2024
Q2 | $31.1M | Buy |
|
|||||
|
2024
Q1 | $39.5M | Buy |
|
|||||
|
2023
Q4 | $20.3M | Buy |
|
|||||
|
2023
Q3 | $15.5M | Buy |
|
|||||
|
2023
Q2 | $16.9M | Buy |
|
|||||
|
2023
Q1 | $15.7M | Buy |
|
|||||
|
2022
Q4 | $16.8M | Buy |
|
|||||
|
2022
Q3 | $11.9M | Buy |
|
|||||
|
2022
Q2 | $7.59M | Buy |
|
|||||
|
2022
Q1 | $14.9M | Buy |
|
|||||
|
2021
Q4 | $15M | Buy |
|
|||||
|
2021
Q3 | $8.42M | Sell |
|
|||||
|
2021
Q2 | $9.37M | Buy |
|
|||||
|
2021
Q1 | $10.7M | Buy |
|
|||||
|
2020
Q4 | $11.1M | Buy |
|
|||||
|
2020
Q3 | $4.24M | Buy |
|
|||||
|
2020
Q2 | $4.02M | Buy |
|